Globeflex Capital L P Meridian Bioscience Inc Transaction History

Globeflex Capital L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$23.75 - $31.69 $594,533 - $793,295	25,033 Added 34.29%	98,041 $2.98 Million
Q3 2021 Nov 12, 2021	SELL	$17.35 - $22.5 $1.96 Million - $2.54 Million	-112,931 Reduced 60.74%	73,008 $1.41 Million
Q2 2021 Aug 12, 2021	BUY	$18.01 - $28.32 $491,222 - $772,428	27,275 Added 17.19%	185,939 $4.12 Million
Q4 2020 Feb 11, 2021	BUY	$15.73 - $21.66 $102,622 - $141,309	6,524 Added 4.29%	158,664 $2.97 Million
Q3 2020 Nov 13, 2020	BUY	$13.54 - $26.41 $153,272 - $298,961	11,320 Added 8.04%	152,140 $2.58 Million
Q2 2020 Aug 12, 2020	BUY	$7.84 - $23.29 $485,774 - $1.44 Million	61,961 Added 78.57%	140,820 $3.28 Million
Q1 2020 May 13, 2020	BUY	$5.57 - $11.5 $439,244 - $906,878	78,859 New	78,859 $662,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.